Table 3.
Characteristics of HEV RNA-positive liver transplant recipients.
| Variables | Case 1 | Case 2 |
|---|---|---|
| Age [years], sex | 60, female | 41, male |
| Living area | Kanto | Kyushu |
| Primary disease | Primary sclerosing cholangitis | Non-alcoholic steatohepatitis, hepatocellular carcinoma |
| Time from transplantation [months] | 8 | 3 |
| Laboratory data at sampling | ||
| WBC [/μL] | 1500 | 6170 |
| Lymphocyte [/μL] | 453 | 882 |
| AST [IU/L] | 23 | 36 |
| ALT [IU/L] | 27 | 48 |
| T-Bil [mg/dL] | 0.8 | 0.4 |
| γ-GT [IU/L] | 81 | 63 |
| Immunosuppression | Tacrolimus, corticosteroids | Tacrolimus, corticosteroids |
| Liver injury episode after transplantation |
+ | + |
| HEV genotype | 3 | 3 |